Rhythm Pharmaceuticals Inc’s recent filing unveils that its Director GOOD JENNIFER L unloaded Company’s shares for reported $1.66 million on Sep 17 ’24. In the deal valued at $52.40 per share,31,751 shares were sold. As a result of this transaction, GOOD JENNIFER L now holds 3,000 shares worth roughly $0.16 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, JENNIFER GOOD bought 31,751 shares, generating $1,572,310 in total proceeds.
Before that, Cramer Pamela J. sold 4,099 shares. Rhythm Pharmaceuticals Inc shares valued at $205,062 were divested by the Chief Human Resources Officer at a price of $50.03 per share. As a result of the transaction, Cramer Pamela J. now holds 13,500 shares, worth roughly $0.72 million.
Guggenheim initiated its Rhythm Pharmaceuticals Inc [RYTM] rating to a Buy in a research note published on October 21, 2024; the price target was $70. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. JMP Securities began covering RYTM with “Mkt outperform” recommendation on September 17, 2024. BofA Securities revised its rating on May 08, 2024. It rated RYTM as “a Neutral” which previously was an “a Buy”.
Price Performance Review of RYTM
On Monday, Rhythm Pharmaceuticals Inc [NASDAQ:RYTM] saw its stock jump 8.12% to $52.99. Over the last five days, the stock has gained 7.20%. Rhythm Pharmaceuticals Inc shares have risen nearly 15.27% since the year began. Nevertheless, the stocks have risen 112.04% over the past one year. While a 52-week high of $55.64 was reached on 09/19/24, a 52-week low of $23.26 was recorded on 05/29/24. SMA at 50 days reached $49.80, while 200 days put it at $44.72.
Levels Of Support And Resistance For RYTM Stock
The 24-hour chart illustrates a support level at 49.76, which if violated will result in even more drops to 46.52. On the upside, there is a resistance level at 54.90. A further resistance level may holdings at 56.81. The Relative Strength Index (RSI) on the 14-day chart is 60.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.02, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 9.88%. Stochastics %K at 40.46% indicates the stock is a holding.
How much short interest is there in Rhythm Pharmaceuticals Inc?
A steep rise in short interest was recorded in Rhythm Pharmaceuticals Inc stocks on 2024-10-15, dropping by -0.88 million shares to a total of 8.46 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 9.34 million shares. There was a decline of -10.41%, which implies that there is a negative sentiment for the stock.
